Kayne Anderson Rudnick Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.6K | Hold |
135
| – | – | ﹤0.01% | 641 |
|
|
2025
Q1 | $32.9K | Hold |
135
| – | – | ﹤0.01% | 611 |
|
|
2024
Q4 | $44.3K | Hold |
135
| – | – | ﹤0.01% | 563 |
|
|
2024
Q3 | $45.2K | Hold |
135
| – | – | ﹤0.01% | 560 |
|
|
2024
Q2 | $36.9K | Hold |
135
| – | – | ﹤0.01% | 553 |
|
|
2024
Q1 | $46.7K | Hold |
135
| – | – | ﹤0.01% | 547 |
|
|
2023
Q4 | $43.6K | Hold |
135
| – | – | ﹤0.01% | 533 |
|
|
2023
Q3 | $48.4K | Hold |
135
| – | – | ﹤0.01% | 515 |
|
|
2023
Q2 | $51.2K | Hold |
135
| – | – | ﹤0.01% | 498 |
|
|
2023
Q1 | $64.7K | Hold |
135
| – | – | ﹤0.01% | 477 |
|
|
2022
Q4 | $56.8K | Hold |
135
| – | – | ﹤0.01% | 502 |
|
|
2022
Q3 | $56K | Hold |
135
| – | – | ﹤0.01% | 472 |
|
|
2022
Q2 | $67K | Hold |
135
| – | – | ﹤0.01% | 461 |
|
|
2022
Q1 | $76K | Hold |
135
| – | – | ﹤0.01% | 444 |
|
|
2021
Q4 | $102K | Hold |
135
| – | – | ﹤0.01% | 448 |
|
|
2021
Q3 | $101K | Hold |
135
| – | – | ﹤0.01% | 433 |
|
|
2021
Q2 | $87K | Hold |
135
| – | – | ﹤0.01% | 445 |
|
|
2021
Q1 | $77K | Hold |
135
| – | – | ﹤0.01% | 437 |
|
|
2020
Q4 | $79K | Hold |
135
| – | – | ﹤0.01% | 420 |
|
|
2020
Q3 | $70K | Hold |
135
| – | – | ﹤0.01% | 404 |
|
|
2020
Q2 | $61K | Hold |
135
| – | – | ﹤0.01% | 393 |
|
|
2020
Q1 | $47K | Buy |
+135
| New | +$47K | ﹤0.01% | 394 |
|